Sourcing Better PDX Models with a Streamlined “Clinic-to-Bench” Pipeline
Discover how XenoSTART’s clinic-to-bench pipeline delivers more clinically relevant PDX models, real-world patient data, and accelerated drug development. Patient-derived xenograft (PDX) models provide the most accurate way to mimic clinical tumor characteristics and behavior in preclinical studies. By directly transplanting tumor tissue from patients into immunodeficient hosts, resulting PDX models preserve the original human tumors’ […]
Sourcing Better PDX Models with a Streamlined “Clinic-to-Bench” Pipeline Read More »
